Schüler T - Search Results

1

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

Becker C, Pohla H, Frankenberger B, Schüler T, Assenmacher M, Schendel DJ, Blankenstein T. Becker C, et al. Among authors: schuler t. Nat Med. 2001 Oct;7(10):1159-62. doi: 10.1038/nm1001-1159. Nat Med. 2001. PMID: 11590442

2

Cutting edge: CD8+ effector T cells reject tumors by direct antigen recognition but indirect action on host cells.

Schüler T, Blankenstein T. Schüler T, et al. J Immunol. 2003 May 1;170(9):4427-31. doi: 10.4049/jimmunol.170.9.4427. J Immunol. 2003. PMID: 12707316

3

B cells inhibit induction of T cell-dependent tumor immunity.

Qin Z, Richter G, Schüler T, Ibe S, Cao X, Blankenstein T. Qin Z, et al. Among authors: schuler t. Nat Med. 1998 May;4(5):627-30. doi: 10.1038/nm0598-627. Nat Med. 1998. PMID: 9585241

4

T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice.

Schüler T, Qin Z, Ibe S, Noben-Trauth N, Blankenstein T. Schüler T, et al. J Exp Med. 1999 Mar 1;189(5):803-10. doi: 10.1084/jem.189.5.803. J Exp Med. 1999. PMID: 10049944 Free PMC article.

5

Tumor rejection by disturbing tumor stroma cell interactions.

Ibe S, Qin Z, Schüler T, Preiss S, Blankenstein T. Ibe S, et al. Among authors: schuler t. J Exp Med. 2001 Dec 3;194(11):1549-59. doi: 10.1084/jem.194.11.1549. J Exp Med. 2001. PMID: 11733570 Free PMC article.

6

Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8(+) T cells.

Schüler T, Kammertoens T, Preiss S, Debs P, Noben-Trauth N, Blankenstein T. Schüler T, et al. J Exp Med. 2001 Dec 17;194(12):1767-75. doi: 10.1084/jem.194.12.1767. J Exp Med. 2001. PMID: 11748278 Free PMC article.

7

Naive CD8(+) but not CD4(+) T cells induce maturation of dendritic cells.

Schüler T, Blankenstein T. Schüler T, et al. J Mol Med (Berl). 2002 Aug;80(8):533-41. doi: 10.1007/s00109-002-0360-4. Epub 2002 Jun 19. J Mol Med (Berl). 2002. PMID: 12185454

8

Immunotherapy: target the stroma to hit the tumor.

Kammertoens T, Schüler T, Blankenstein T. Kammertoens T, et al. Among authors: schuler t. Trends Mol Med. 2005 May;11(5):225-31. doi: 10.1016/j.molmed.2005.03.002. Trends Mol Med. 2005. PMID: 15882610 Review.

9

Interleukin 4 gene-defective mice reconstituted with wild-type bone marrow fail to produce normal immunoglobulin E levels.

Lange C, Schüler T, Blankenstein T. Lange C, et al. Among authors: schuler t. J Exp Med. 1998 May 4;187(9):1487-93. doi: 10.1084/jem.187.9.1487. J Exp Med. 1998. PMID: 9565640 Free PMC article.

10

Cross-priming versus cross-tolerance: are two signals enough?

Blankenstein T, Schüler T. Blankenstein T, et al. Among authors: schuler t. Trends Immunol. 2002 Apr;23(4):171-3. doi: 10.1016/s1471-4906(02)02185-3. Trends Immunol. 2002. PMID: 11923104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page